The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta‐analytical review
Abstract
Aims To determine the efficacy of naltrexone in reducing illicit opioid use and the potential moderating role of treatment retention. Design First, randomized controlled trials (RCTs) comparing the regimens of treatment using the opioid antagonist, naltrexone, with controls were analysed by meta‐analysis for treatment effect with regard to a range of outcome criteria. The degree of heterogeneity was also determined. The moderating effect of other interventions during naltrexone maintenance was then estimated, particularly with regard to their effect on treatment retention. Participants Fifteen studies involving 1071 patients were found. Measurements All available outcomes were analysed in 10 studies of naltrexone versus control (seven placebo) and six studies of randomized psychosocial/psychopharmacological interventions. Findings Significant heterogeneity was found in the efficacy of naltrexone. Level of retention in treatment was found to be a moderator, explaining most of the heterogeneity found. Overall, naltrexone was significantly better than control conditions in reducing the number of opioid‐positive urines. This effect was only present in the high retention subgroup for differences in retention. Contingency management (CM) increased retention and naltrexone use, resulting in a reduced number of opioid‐positive urines. Conclusion Retention is important to the effect of naltrexone in treating opioid dependence. Contingency management is a promising method of increasing retention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Statistical Methods for Rates and Proportions.
Everitt, B. S., & Fleiss, J. L. (1981) · Biometrics · doi:10.2307/2530193 · Cited by 8,990
Statistical Methods for Meta-Analysis.
Freeman, P. R., Hedges, L. V., & Olkin, I. (1986) · Biometrics · doi:10.2307/2531069 · Cited by 4,784
The Handbook of Research Synthesis.
Light, R. J., Cooper, H., & Hedges, L. V. (1994) · Journal of the American Statistical Association · doi:10.2307/2291021 · Cited by 1,868
Moyer, A., Finney, J. W., Swearingen, C. E., & Vergun, P. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00018.x · Cited by 1,092
Pharmacological Treatment of Alcohol Dependence: A Review of the Evidence
Garbutt, J. C., West, S. L., Carey, T. S., Lohr, K. N., & Crews, F. T. (1999) · JAMA · doi:10.1001/jama.281.14.1318 · Cited by 444
Role of maintenance treatment in opioid dependence
Ward, J., Hall, W., & Mattick, R. P. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05356-2 · Cited by 424
The pharmacological treatment of alcohol dependence.
Swift, R. M. (1997) · PubMed · Cited by 372
Naltrexone pharmacotherapy for opioid dependent federal probationers
Cornish, J. W., Metzger, D., Woody, G. E., Wilson, D., McLellan, A. T., Vandergrift, B., & O'Brien, C. P. (1997) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(97)00020-2 · Cited by 215
Poikolainen, K. (1999) · Preventive Medicine · doi:10.1006/pmed.1999.0467 · Cited by 211
Carroll, K. M., Ball, S. A., Nich, C., O'Connor, P. G., Eagan, D. A., Frankforter, T. L., Triffleman, E. G., Shi, J., & Rounsaville, B. J. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.8.755 · Cited by 197
Pharmacologic Treatment of Heroin-Dependent Patients
O'Connor, P. G., & Fiellin, D. A. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00008 · Cited by 183
Treatment of Alcohol Abuse: An Evidence‐Based Review
Berglund, M., Thelander, S., Salaspuro, M. P., Franck, J., Andréasson, S., & Öjehagen, A. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000090144.99832.19 · Cited by 164
Self-citationImprovement in naltrexone treatment compliance with contingency management
Preston, K. L., Silverman, K., Umbricht, A., DeJesus, A., Montoya, I. D., & Schuster, C. R. (1999) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00152-5 · Cited by 164
Treating Alcohol and Drug Abuse: An Evidence Based Review
(2003) · Wiley eBooks · doi:10.1002/3527601465 · Cited by 117
Behavioral family counseling and naltrexone for male opioid-dependent patients.
Fals-Stewart, W., & O'Farrell, T. J. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.3.432 · Cited by 116
Carroll, K. M., Sinha, R., Nich, C., Babuscio, T. A., & Rounsaville, B. J. (2002) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.10.1.54 · Cited by 112
A systematic review on the efficacy of naltrexone maintenance treatment in opioid dependence
Kirchmayer, U., Davoli, M., Verster, A. D., Amato, L., Ferri, A., & Perucci, C. A. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00217.x · Cited by 106
Operant analysis of human heroin self-administration and the effects of naltrexone.
Mello, N. K., Mendelson, J. H., Kuehnle, J. C., & Sellers, M. S. (1981) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32374-8 · Cited by 106
Naltrexone for heroin dependence treatment in St. Petersburg, Russia
Krupitsky, E. M., Zvartau, E. E., Masalov, D. V., Tsoi, M. V., Burakov, A. M., Egorova, V. Y., Didenko, T., Romanova, T. N., Ivanova, E. B., Bespalov, A., et al. (2004) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2004.02.002 · Cited by 103
(1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770270085008 · Cited by 103
Clonidine and opiate receptor antagonists in the treatment of heroin addiction
Gerra, G., Marcato, A., Caccavari, R., Fontanesi, B., Delsignore, R., Affini, G. F., Avanzini, P., Rustichelli, P., & Passeri, M. (1995) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(94)00077-8 · Cited by 90
The efficacy of naltrexone in preventing reabuse of heroin after detoxification
Shufman, E., Porat, S., Witztum, E., Gandacu, D., Bar‐Hamburger, R., & Ginath, Y. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)91240-8 · Cited by 84
Follow‐up after a six‐month maintenance period on naltrexone versus placebo in heroin addicts
SAN, L., POMAROL, G., Peri, J., OLLE, J. M., & Camı́, J. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01859.x · Cited by 78
Brahen, L. S. (1977) · Archives of General Psychiatry · doi:10.1001/archpsyc.1977.01770220063007 · Cited by 40
A naltrexone double blind placebo controlled study in Israel.
Lerner, A., Sigal, M., Bacalu, A., Shiff, R., Burganski, I., & Gelkopf, M. (1992) · PubMed · Cited by 36
A randomised, controlled trial of low dose naltrexone for the treatment of opioid dependence
Rea, F., Bell, J. R., Young, M. R., & Mattick, R. P. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.02.003 · Cited by 35
Psychosocial factors in outcome in two opiate addiction treatments
Grey, C. C., Osborn, E., & Reznikoff, M. (1986) · Journal of Clinical Psychology · doi:10.1002/1097-4679(198601)42:1<185::aid-jclp2270420132>3.0.co;2-w · Cited by 29
Naltrexone and Behavior Therapy for Heroin Addiction
Rawson, R. A., Glazer, M., Callahan, E. J., & Liberman, R. P. (1979) · PsycEXTRA Dataset · doi:10.1037/e497382006-005 · Cited by 21
Curran, S. F., & Savage, C. (1976) · PsycEXTRA Dataset · doi:10.1037/e497452006-012 · Cited by 19
Guo, S., Jiang, Z., & Wu, Y. (2001) · Hong Kong journal of psychiatry · Cited by 18
A randomized control trial of group counseling in a naltrexone treatment program
Tucker, T., Ritter, A. J., Maher, C., & Jackson, H. J. (2004) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2004.08.003 · Cited by 17
Psychosocial Adjustment, Modality Choice, and Outcome in Naltrexone versus Methadone Treatment
Osborn, E., Grey, C. C., & Reznikoff, M. (1986) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952998609016877 · Cited by 15
Five-year follow-up of opiate addicts with naltrexone and behavior therapy.
Rawson, R. A., & Tennant, F. S. (1984) · PsycEXTRA Dataset · doi:10.1037/e473622004-001 · Cited by 14
Varying Clinical Contexts for Administering Naltrexone
Hurzeler, M., Gerwirtz, D., & Kleber, H. D. (1976) · PsycEXTRA Dataset · doi:10.1037/e497452006-011 · Cited by 13
Ladewig, D. (1990) · PubMed · Cited by 9
The Double-Blind Crossover Trial Design: How Good Is It for Psychoactive Drugs?
Brahen, L. S., Capone, T. A., & Wojak, J. C. (1979) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952997909007044 · Cited by 5
Cited by
Treatment of opioid-use disorders
Schuckit, M. A. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1604339 · Cited by 540
Retention in medication-assisted treatment for opiate dependence: A systematic review
Timko, C., Schultz, N. R., Cucciare, M. A., Vittorio, L., & Garrison-Diehn, C. (2016) · Journal of Addictive Diseases · doi:10.1080/10550887.2016.1100960 · Cited by 489
Veilleux, J. C., Colvin, P. J., Anderson, J., York, C., & Heinz, A. J. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.10.006 · Cited by 336
Ceceli, A. O., Bradberry, C. W., & Goldstein, R. Z. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01153-9 · Cited by 150
Schottenfeld, R. S., Chawarski, M. C., & Mazlan, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60954-x · Cited by 99
Metadata
- Authors
- Johansson, B. A., Berglund, M., & Lindgren, A.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2006-02-14
- Volume
- 101
- Issue
- 4
- Pages
- 491-503
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W2145849285
- Cited by
- 305
- References
- 37
- FWCI
- 8.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.